With Novo Nordisk’s pill version of Wegovy now widely available, GLP-1 drugs are poised for even greater adoption. That surge is fueling awareness of the link between obesity and sleep apnea – and driving demand for sleep testing, says Vick Tipnes, CEO and founder of Blackstone Medical Services. Fortunately, people recognize there’s a connection between health concerns like being overweight and the risk of having sleep apnea – and that’s driving an uptick in sleep testing, says Vick Tipnes, CEO & founder of Blackstone Medical Services, a national provider of home sleep testing services.
Read the full article: As GLP-1 Use Rises, so Does Awareness of Sleep Apnea, Says Blackstone Medical Services CEO //
Source: https://www.hmenews.com/article/as-glp-1-use-rises-so-does-awareness-of-sleep-apnea-says-blackstone-ceo